Maravai Lifesciences Holdings Cash Flow Statement (2020-2026) | MRVI

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
134.50M132.18M127.11M146.86M156.72M99.65M87.43M-1.35M-11.94M-15.10M-109.98M-22.68M-18.42M-172.46M-46.07M-52.85M-69.84M-45.06M-63.02M-6.38M
Depreciation and Depletion (Quarter)
1.61M1.80M1.73M1.85M1.89M1.86M1.96M2.08M2.81M4.07M3.93M4.79M5.56M5.04M5.51M5.69M5.96M5.97M5.97M4.90M
Share-based Compensation (Quarter)
2.38M3.57M2.23M3.63M4.31M4.74M6.00M5.99M9.27M9.99M9.34M12.06M13.76M13.05M10.54M10.40M6.79M9.06M3.93M6.74M
Deferred Taxes (Quarter)
6.45M11.23M17.47M13.22M12.86M9.23M7.01M-1.52M-2.76M-5.53M764.75M0.01M
Gains from Investment Securities (Quarter)
-7.80M-7.80M-2.07M0.33M-2.32M2.38M-28.93M0.14M-1.20M-0.18M-0.23M0.14M-1.75M1.29M-0.54M
Asset Writedowns and Impairment (Quarter)
12.44M4.90M0.60M
Cash from Operations (Quarter)
165.94M105.56M58.74M162.30M164.28M110.06M99.33M85.07M19.19M14.17M7.79M-8.47M17.43M13.14M-14.64M-9.39M-10.27M-15.15M-22.77M8.66M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
154.24M30.40M
Amortizatization of Intangibles (Quarter)
1.90M3.10M3.68M5.53M5.60M0.70M6.24M2.06M0.70M6.20M6.87M2.10M6.20M6.20M2.16M7.03M0.60M6.60M2.29M1.61M
Amortization of Deferred Charges (Quarter)
0.90M0.68M0.70M0.71M0.72M0.65M0.72M0.73M0.74M0.74M0.74M0.74M0.75M0.66M0.46M0.39M0.40M0.40M
Depreciation & Amortization (CF) (Quarter)
1.61M1.80M1.73M1.85M1.89M1.86M1.96M2.08M2.81M4.07M3.93M4.79M5.56M5.04M5.51M5.69M5.96M5.97M5.97M4.90M
Change in Working Capital
Change in Receivables (Quarter)
-34.34M-17.62M51.54M2.22M0.12M-5.83M25.77M-82.41M-7.56M-3.21M8.79M-17.88M-1.89M-6.02M11.43M-10.16M-0.50M-5.12M2.96M7.91M
Change in Inventory (Quarter)
4.69M8.56M-5.48M-1.20M8.70M2.31M-19.27M3.38M-7.71M1.50M2.18M-0.82M-0.70M1.60M-0.45M-0.45M-3.11M-1.35M-3.09M-0.03M
Change in Account Payables (Quarter)
2.27M-2.62M-0.87M1.95M4.36M-4.42M-3.47M-0.23M1.87M1.99M1.66M-3.68M4.57M-2.42M2.25M-0.71M1.78M-2.91M-5.51M6.16M
Change in Accured Expenses (Quarter)
-1.80M1.62M7.47M-4.06M2.29M15.89M-5.61M24.23M-17.64M2.38M6.40M-24.12M3.00M-1.06M-1.56M1.84M5.54M1.51M-13.51M-5.34M
Other Working Capital Changes (Quarter)
-36.04M0.97M-10.56M-2.52M-2.26M6.53M-8.87M-10.60M12.32M-3.48M-5.51M-0.73M-4.12M3.88M0.82M-2.24M-12.44M14.23M0.26M-1.43M
Investing Activities
Capital Expenditures (Quarter)
4.53M-7.00M1.28M2.75M1.66M-2.61M15.29M7.87M-5.11M45.99M16.80M3.16M12.06M8.59M5.85M1.43M0.29M-0.81M12.23M4.44M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)
0.50M
Acquisitions (Quarter)
238.84M0.13M69.73M-0.11M18.63M0.36M
Divestments (Quarter)
120.70M
Cash from Investing Activities (Quarter)
-4.53M118.63M-5.66M-241.58M-1.66M-5.85M-18.52M-69.73M-24.16M-15.52M-12.90M-4.24M-6.18M-8.96M-4.93M-23.13M-3.24M-2.93M-2.11M-4.44M
Financing Activities
Other financing activities (Quarter)
0.49M1.40M1.96M2.32M2.38M2.34M2.35M-5.82M-3.54M4.92M-1.38M-3.87M
Cash from Financing Activities (Quarter)
-34.13M-51.28M-49.58M-40.52M-43.41M-37.44M-66.12M-19.21M-43.13M0.78M0.47M-0.56M0.23M0.81M-236.19M-4.90M-1.53M-8.25M-1.82M-55.23M
Dividend Payments
Dividends Paid - Common (Quarter)
33.08M50.09M110.00M39.89M42.59M36.81M30.92M8.30M1.30M0.57M-0.08M
Additional items
Exchange Rate Effect (Quarter)
0.01M0.03M-0.13M0.07M-0.11M-0.01M0.01M0.03M
Change in Cash (Quarter)
127.28M172.94M3.37M-119.80M119.21M66.77M14.69M-3.87M-48.10M-0.57M-4.64M-13.27M11.48M4.99M-255.76M-37.35M-15.15M-26.33M-26.68M-50.97M
Free Cash Flow (Quarter)
161.41M112.56M57.46M159.56M162.62M112.67M84.04M77.21M24.30M-31.82M-9.01M-11.63M5.38M4.54M-20.49M-10.82M-10.55M-14.34M-35.00M4.23M
Net Cash Flow (Quarter)
127.28M172.91M3.51M-119.80M119.21M66.77M14.69M-3.87M-48.10M-0.57M-4.64M-13.27M11.48M4.99M-255.76M-37.42M-15.04M-26.32M-26.70M-51.00M